Even with two other vaccines authorized, Novavax is having no trouble recruiting volunteers for its U.S. trial. If all goes well, the U.S. could see 110 million doses in June.
Published: February 3, 2021 at 08:11PM
from NYT Health https://ift.tt/36HyOiS